Open AccessA Two-cohort Phase I Study of Weekly Oxaliplatin and Gemcitabine, Then Oxaliplatin, Gemcitabine, and Erlotinib During Radiotherapy for Unresectable Pancreatic Carcinoma
Author(s) -
Laura Raftery,
Joel E. Tepper,
Richard M. Goldberg,
A. William Blackstock,
Mebea Aklilu,
Stephen A. Bernard,
Anastasia Ivanova,
Janine M. Davies,
Bert H. O’Neil
Publication year - 2013
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/5pb0-4m76
Subject(s) - gemcitabine , oxaliplatin , erlotinib , medicine , oncology , radiation therapy , cohort , chemotherapy , colorectal cancer , cancer , epidermal growth factor receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom